Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Vincent Bernard Pagan Image

      Vincent Bernard Pagan, MD, PHD

      Department of GI Radiation Oncology, Division of Radiation Oncology

      About Dr. Vincent Bernard Pagan

      Vincent Bernard Pagan, M.D., Ph.D. is a physician scientist and Assistant Professor in the Department of Gastrointestinal Radiation Oncology at The University of Texas MD Anderson Cancer Center. His clinical and research focus is on gastrointestinal malignancies, with a particular emphasis on upper GI cancers. Dr. Bernard Pagan leads a translational research program that integrates single cell and spatial transcriptomic technologies to dissect how cancer cells and the tumor microenvironment respond and adapt to therapy. His work seeks to define mechanisms of resistance to targeted agents and radiation therapy, identify therapeutic vulnerabilities, and develop rational combinatorial strategies to overcome treatment resistance He has been recognized with several awards for his contributions to cancer research, including the ASCO Conquer Cancer Foundation Young Investigator Award and the Lustgarten Foundation-AACR Career Development Award.

      Read More

      In the News

      Man with facial hair wearing glass and a white lab coat

      4 things I learned from my radiation oncology training at MD Anderson

      Present Title & Affiliation

      Dual/Joint/Adjunct Appointment

      Assistant Professor, GI Radiation Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2020University of Puerto Rico School of Medicine, San Juan, Puerto Rico, US, Doctor of Medicine (MD)
      2020University of Texas Health Science Center at Houston, Houston, Texas, US, PhD in Cancer Biology & Molecular Genetics
      2010Johns Hopkins University, Baltimore, Maryland, US, Master of Science (Biotechnology)
      2009Johns Hopkins University, Baltimore, Maryland, US, Bachelor of Science (Chemical and Biomolecular Engineering)

      Postgraduate Training

      2021-2025Resident, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2020-2021Resident, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Licenses & Certifications

      2025Texas Medical Board

      Honors & Awards

      2024Ann Eastland Spears Fellowship in Pancreatic Cancer Research
      2024Harter Prize, MD Anderson Cancer Center
      2024Scholar-In-Training Travel Award, Radiation Research Society Annual Meeting, Tucson, AZ
      2024Annual Meeting Travel Award, Biology Section, ASTRO Annual Meeting, Washington, DC
      2024AACR Let’s Win Pancreatic Cancer Scholar-in-Training Award, Boston, MA
      2024Trainee Peer-to Peer Clinical Mentor Award, MD Anderson Cancer Center
      2023Holman Research Pathway Fellow, MD Anderson Cancer Center
      2023AACR-Doreen J. Putrah Cancer Research Foundation Scholar-in-Training Award, AACR Annual Meeting; Orlando, FL
      2023ASCO/AACR Methods in Clinical Cancer Research Workshop, San Diego, CA
      2022Ann Eastland Spears Fellowship in Pancreatic Cancer Research
      2019The Harold C. and Mary L. Daily Endowment Fellowship
      2018Chinese Society of Clinical Oncology Young Investigator Travel Award, Xiamen, China
      2017American Legion Auxiliary Fellowship, MD Anderson UTHealth Graduate School
      2017American Radium Society: Young Oncologist Essay Award, Colorado Springs, CO
      2017President’s Research Scholarship, MD Anderson UTHealth Graduate School
      2016Sylvan Rodriguez Foundation Scholarship honoring George M. Stancel, Ph.D, MD Anderson UTHealth Graduate School
      2014Alpha Omega Alpha Honor Medical Society, University of Puerto Rico School of Medicine

      Selected Presentations & Talks

      Local Presentations

      1. 2024. Characterizing Radiation Induced Subclonal Kinetics in Pancreatic Ductal Adenocarcinoma. ASTRO Annual Meeting.
      2. 2024. Deciphering the subclonal kinetics and molecular responses to stereotactic body radiation therapy in pancreatic cancer. RRS.
      3. 2023. Radiomodulation of pancreatic cancer. MD Anderson Research Town Hall.
      4. 2018. Rare Cells in Circulation as Biomarkers of Chemorefractory Status in Pancreatic Cancer. Gordon Research Symposium: Liquid Biopsy for Cancer.
      5. 2018. Near real-time tumor monitoring of pancreatic cancers through liquid biopsies. 10th Annual Cullen MD/PhD Colloquium & Workshop.
      6. 2017. Heterogeneity in treatment response of spine metastases to spine stereotactic radiosurgery within “radiosensitive” subtypes. American Radium Society 99th Annual Meeting.
      Read More
      Less

      Grant & Contract Support

      Date: 2026 - 2030
      Title:Break Through Cancer Conquering KRAS
      Funding Source:Break Thorugh Cancer
      Role:PI
      Date: 2025 - 2027
      Title:Characterizing the role of ferroptosis modulation for radiosensitization in gastrointestinal malignancies
      Funding Source:Project Purple
      Role:PI
      Date: 2025 - 2026
      Title:Enhancing Copper Dependent Cell Death through Metabolic Priming in PDAC
      Funding Source:Shelby-Lavine Pancreatic Scholar Program
      Role:PI
      Date: 2025 - 2026
      Title:Tumor Maps to Guide Next Generation Immune Cell Therapy
      Funding Source:Ben and Rose Cole PRIA Foundation
      Role:PI
      Date: 2025 - 2028
      Title:Lustgarten-AACR Career Development Award
      Funding Source:Lustgarten-AACR
      Role:PI
      Date: 2024
      Title:Harter Prize
      Funding Source:Harter
      Role:PI
      Date: 2023
      Title:Conquer Cancer ASCO Young Investigator Award
      Funding Source:ASCO
      Role:PI
      ID:2023YIA-9884975893
      Date: 2023
      Title:MDACC SPORE in GI Cancer Career Enhancement Program
      Funding Source:MDACC SPORE
      Role:PI
      Date: 2022 - 2026
      Title:Break Through Cancer Demystifying Pancreatic Cancer
      Funding Source:Break Through Cancer
      Role:PI
      Date: 2022
      Title:MD Anderson – QIAC Partnership in Research (QPR) Grants
      Funding Source:QPR
      Role:PI
      Date: 2018 - 2019
      Title:NIH T32 Postdoctoral Research Fellow
      Funding Source:NIH
      Role:PI
      ID:CA217789-01A1
      Date: 2015 - 2018
      Title:Cancer Prevention Research Institute of Texas (CPRIT) Scholar Training Grant
      Funding Source:CPRIT
      Role:PI
      ID:RP140106

      Selected Publications

      Peer-Reviewed Articles

      1. Ku, LT, Bernard-Pagan, V, Min, J, Yuan, Y, Koay, EJ, Maitra, A, Li, L, Li, Z. Benchmarking tools for deciphering cellular crosstalk in spatially-resolved transcriptomics. Genome biology 27(1), 2026. e-Pub 2026. PMID: 41952215.
      2. Min, J, Schweizer, L, Zonderland, G, Chellakkan Selvanesan, B, Thomsen, JH, Oldenburg, L, Bae, SW, Kim, B, Hernandez, S, Jez, G, Bernard-Pagan, V, Swanson, BJ, Klute, K, Wang, H, Caffrey, TC, Grandgenett, PM, Hollingsworth, MA, Ummat, I, Strauss, MT, Mund, A, Maitra, A. AI-Powered Deep Visual Proteomics Reveals Critical Molecular Transitions in Pancreatic Cancer Precursors. Cancer discovery 16(7):1323-1340, 2026. e-Pub 2026. PMID: 42013410.
      3. Dohmen, J, De Santis, L, Stephens, BM, Bernard-Pagan, V, Kalff, JC, Braun, L, Leyendecker, P, Röttgen, J, Weissinger, D, Maitra, A, Guerrero, PA, Semaan, A. Pre-analytical optimization of cell-free DNA and extracellular vesicle-derived DNA for mutation detection in liquid biopsies. Molecular oncology 20(7):1762-1779, 2026. e-Pub 2026. PMID: 41725045.
      4. Ting T, Bernard V, Min J, Yuan Y, Koay E, Maitra A, Li Liang, Li Z. Benchmarking tools for deciphering cellular crosstalk in spatially-resolved transcriptomics. Genome Biology, 2026. e-Pub 2026. PMID: 41952223.
      5. Asif, A, Asif, A, Rooney, M, Chang, E, Namayanja, F, Quentin, K, Lee, S, Hu, I, Bernard-Pagan, V, Das, P, Holiday, EB, Noticewala, SS, Smith, GL, Koong, A, Ludmir, EB, Javle, M, Xiao, L, Koay, EJ. Safety and efficacy of liver-directed radiotherapy after chemoimmunotherapy for advanced cholangiocarcinoma. Journal of Gastrointestinal Oncology 16(5):2146-2157, 2025. e-Pub 2025. PMID: 41220722.
      6. Pei G, Min J, Rajapakshe KI, Branchi V, Liu Y, Selvanesan BC, Thege F, Sadeghian D, Zhang D, Cho KS, Chu Y, Dai E, Han G, Li M, Yee C, Takahashi K, Garg B, Tiriac H, Bernard V, Semaan A, Grem JL, Caffrey TC, Burks JK, Lowy AM, Aguirre AJ, Grandgenett PM, Hollingsworth MA, Guerrero PA, Wang L, Maitra A. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Nature 642(8066):212-221, 2025. e-Pub 2025. PMID: 40269162.
      7. Beckham TH, Rooney MK, Cifter G, Bernard V, McAleer MF, De BS, Tom MC, Perni S, Wang C, Swanson T, Tatsui CE, Alvarez-Breckenridge C, North R, Rhines LD, Tang C, Logothetis C, Amini B, Li J, Yeboa DN, Ghia AJ. Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approach. J Neurosurg Spine 41(3):436-444, 2024. e-Pub 2024. PMID: 38875722.
      8. Taniguchi CM, Frakes JM, Aguilera TA, Palta M, Czito B, Bhutani MS, Colbert LE, Abi Jaoude J, Bernard V, Pant S, Tzeng CD, Kim DW, Malafa M, Costello J, Mathew G, Rebueno N, Koay EJ, Das P, Ludmir EB, Katz MHG, Wolff RA, Beddar S, Sawakuchi GO, Moningi S, Slack Tidwell RS, Yuan Y, Thall PF, Beardsley RA, Holmlund J, Herman JM, Hoffe SE. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. Lancet Oncol 24(12):1387-1398, 2023. e-Pub 2023. PMID: 38039992.
      9. Kolbinger FR, Bernard V, Lee JJ, Stephens BM, Branchi V, Raghav KPS, Maitra A, Guerrero PA, Semaan A. Significance of Distinct Liquid Biopsy Compartments in Evaluating Somatic Mutations for Targeted Therapy Selection in Cancer of Unknown Primary. J Gastrointest Cancer 54(4):1276-1285, 2023. e-Pub 2023. PMID: 36862364.
      10. Semaan A, Bernard V, Wong J, Makino Y, Swartzlander DB, Rajapakshe KI, Lee JJ, Officer A, Schmidt CM, Wu HH, Scaife CL, Affolter KE, Nachmanson D, Firpo MA, Yip-Schneider M, Lowy AM, Harismendy O, Sen S, Maitra A, Jakubek YA, Guerrero PA. Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project. Cancer Res Commun 3(10):2062-2073, 2023. e-Pub 2023. PMID: 37721516.
      11. De B, Upadhyay R, Liao K, Kumala T, Shi C, Dodoo G, Abi Jaoude J, Corrigan KL, Manzar GS, Marqueen KE, Bernard V, Lee SS, Raghav KPS, Vauthey JN, Tzeng CD, Tran Cao HS, Lee G, Wo JY, Hong TS, Crane CH, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer 12(3):198-208, 2023. e-Pub 2023. PMID: 37593365.
      12. Hill CS, Rosati L, Wang H, Tsai HL, He J, Hacker-Prietz A, Laheru DA, Zheng L, Sehgal S, Bernard V, Le DT, Pawlik TM, Weiss MJ, Narang AK, Herman JM. Multiagent Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Prospective Nonrandomized Controlled Trial. Pract Radiat Oncol 12(6):511-523, 2022. e-Pub 2022. PMID: 35306231.
      13. Monberg ME, Geiger H, Lee JJ, Sharma R, Semaan A, Bernard V, Wong J, Wang F, Liang S, Swartzlander DB, Stephens BM, Katz MHG, Chen K, Robine N, Guerrero PA, Maitra A. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution. Nat Commun 13(1):3652, 2022. e-Pub 2022. PMID: 35752636.
      14. Garcia Garcia CJ, Huang Y, Fuentes NR, Turner MC, Monberg ME, Lin D, Nguyen ND, Fujimoto TN, Zhao J, Lee JJ, Bernard V, Yu M, Delahoussaye AM, Jimenez Sacarello I, Caggiano EG, Phan JL, Deorukhkar A, Molkentine JM, Saur D, Maitra A, Taniguchi CM. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. Gastroenterology 162(7):2018-2031, 2022. e-Pub 2022. PMID: 35216965.
      15. Lee JJ, Bernard V, Semaan A, Monberg ME, Huang J, Stephens BM, Lin D, Rajapakshe KI, Weston BR, Bhutani MS, Haymaker CL, Bernatchez C, Taniguchi CM, Maitra A, Guerrero PA. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Clin Cancer Res 27(21):5912-5921, 2021. e-Pub 2021. PMID: 34426439.
      16. Semaan A, Bernard V, Kim DU, Lee JJ, Huang J, Kamyabi N, Stephens BM, Qiao W, Varadhachary GR, Katz MH, Shen Y, San Lucas FA, Gascoyne P, Alvarez HA, Maitra A, Guerrero PA. Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer. Br J Cancer 124(12):1970-1977, 2021. e-Pub 2021. PMID: 33785875.
      17. Semaan A, Bernard V, Lee JJ, Wong JW, Huang J, Swartzlander DB, Stephens BM, Monberg ME, Weston BR, Bhutani MS, Chang K, Scheet PA, Maitra A, Jakubek YA, Guerrero PA. Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples. Clin Cancer Res 27(4):1082-1093, 2021. e-Pub 2021. PMID: 33188144.
      18. Dey P, Li J, Zhang J, Chaurasiya S, Strom A, Wang H, Liao WT, Cavallaro F, Denz P, Bernard V, Yen EY, Genovese G, Gulhati P, Liu J, Chakravarti D, Deng P, Zhang T, Carbone F, Chang Q, Ying H, Shang X, Spring DJ, Ghosh B, Putluri N, Maitra A, Wang YA, DePinho RA. Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment. Cancer Discov 10(4):608-625, 2020. e-Pub 2020. PMID: 32046984.
      19. Kamyabi N, Huang J, Lee JJ, Bernard V, Semaan A, Stephens B, Hurd MW, Vanapalli SA, Maitra A, Guerrero PA. A microfluidic device for label-free isolation of tumor cell clusters from unprocessed blood samples. Biomicrofluidics 13(4):044111, 2019. e-Pub 2019. PMID: 31462955.
      20. Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HA. Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. Clin Cancer Res 25(7):2194-2205, 2019. e-Pub 2019. PMID: 30385653.
      21. Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Tripathi SC, Dhillon DS, Momin AA, Peters H, Katz MH, Alvarez H, Bernard V, Ferri-Borgogno S, Brand R, Adler DG, Firpo MA, Mulvihill SJ, Molldrem JJ, Feng Z, Taguchi A, Maitra A, Hanash SM. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nat Commun 10(1):254, 2019. e-Pub 2019. PMID: 30651550.
      22. Bernard V, Kim DU, San Lucas FA, Castillo J, Allenson K, Mulu FC, Stephens BM, Huang J, Semaan A, Guerrero PA, Kamyabi N, Zhao J, Hurd MW, Koay EJ, Taniguchi CM, Herman JM, Javle M, Wolff R, Katz M, Varadhachary G, Maitra A, Alvarez HA. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. Gastroenterology 156(1):108-118.e4, 2019. e-Pub 2019. PMID: 30240661.
      23. Wolff RA, Wang-Gillam A, Alvarez H, Tiriac H, Engle D, Hou S, Groff AF, San Lucas A, Bernard V, Allenson K, Castillo J, Kim D, Mulu F, Huang J, Stephens B, Wistuba II, Katz M, Varadhachary G, Park Y, Hicks J, Chinnaiyan A, Scampavia L, Spicer T, Gerhardinger C, Maitra A, Tuveson D, Rinn J, Lizee G, Yee C, Levine AJ. Dynamic changes during the treatment of pancreatic cancer. Oncotarget 9(19):14764-14790, 2018. e-Pub 2018. PMID: 29599906.
      24. Castillo J, Bernard V, San Lucas FA, Allenson K, Capello M, Kim DU, Gascoyne P, Mulu FC, Stephens BM, Huang J, Wang H, Momin AA, Jacamo RO, Katz M, Wolff R, Javle M, Varadhachary G, Wistuba II, Hanash S, Maitra A, Alvarez H. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol 29(1):223-229, 2018. e-Pub 2018. PMID: 29045505.
      25. Sakellariou-Thompson D, Forget MA, Creasy C, Bernard V, Zhao L, Kim YU, Hurd MW, Uraoka N, Parra ER, Kang Y, Bristow CA, Rodriguez-Canales J, Fleming JB, Varadhachary G, Javle M, Overman MJ, Alvarez HA, Heffernan TP, Zhang J, Hwu P, Maitra A, Haymaker C, Bernatchez C. 4-1BB Agonist Focuses CD8(+) Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer. Clin Cancer Res 23(23):7263-7275, 2017. e-Pub 2017. PMID: 28947567.
      26. Bernard V, Bishop AJ, Allen PK, Amini B, Wang XA, Li J, Tatsui CE, Rhines LD, Brown PD, Ghia AJ. Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes. Int J Radiat Oncol Biol Phys 99(5):1207-1215, 2017. e-Pub 2017. PMID: 29029886.
      27. Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ, Foretova L, Fabianova E, Holcatova I, Janout V, Meric-Bernstam F, Gascoyne P, Wistuba I, Varadhachary G, Brennan P, Hanash S, Li D, Maitra A, Alvarez H. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Ann Oncol 28(4):741-747, 2017. e-Pub 2017. PMID: 28104621.
      28. San Lucas FA, Allenson K, Bernard V, Castillo J, Kim DU, Ellis K, Ehli EA, Davies GE, Petersen JL, Li D, Wolff R, Katz M, Varadhachary G, Wistuba I, Maitra A, Alvarez H. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes. Ann Oncol 27(4):635-41, 2016. e-Pub 2016. PMID: 26681674.
      29. Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, Marini JC, Tudawe T, Seviour EG, San Lucas FA, Alvarez H, Gupta S, Maiti SN, Cooper L, Peehl D, Ram PT, Maitra A, Nagrath D. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife 5:e10250, 2016. e-Pub 2016. PMID: 26920219.
      30. Kang J, Huang J, Gailloud P, Rigamonti D, Lim M, Bernard V, Ehtiati T, Ford EC. Planning evaluation of C-arm cone beam CT angiography for target delineation in stereotactic radiation surgery of brain arteriovenous malformations. Int J Radiat Oncol Biol Phys 90(2):430-7, 2014. e-Pub 2014. PMID: 25015197.
      31. Echeverria AE, McCurdy M, Castillo R, Bernard V, Ramos NV, Buckley W, Castillo E, Liu P, Martinez J, Guerrero T. Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients. Radiother Oncol 106(1):124-9, 2013. e-Pub 2013. PMID: 23127772.
      32. Barnett BP, Hwang Y, Taylor MS, Kirchner H, Pfluger PT, Bernard V, Lin YY, Bowers EM, Mukherjee C, Song WJ, Longo PA, Leahy DJ, Hussain MA, Tschop MH, Boeke JD, Cole PA. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 330(6011):1689-92, 2010. e-Pub 2010. PMID: 21097901.

      Review Articles

      1. Rooney MK, Andring LM, Corrigan KL, Bernard V, Williamson TD, Fuller CD, Garden AS, Gunn B, Lee A, Moreno AC, Morrison WH, Phan J, Rosenthal DI, Spiotto M, Frank SJ. Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio. Cancers (Basel) 15(17), 2023. e-Pub 2023. PMID: 37686597.
      2. Kamyabi N, Bernard V, Maitra A. Liquid biopsies in pancreatic cancer. Expert Rev Anticancer Ther 19(10):869-878, 2019. e-Pub 2019. PMID: 31533487.
      3. Bernard V, Fleming J, Maitra A. Molecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant?. Surg Oncol Clin N Am 25(2):227-38, 2016. e-Pub 2016. PMID: 27013361.

      Other Articles

      1. Bild, AH, Sangar, MC, McQuerry, JA, Ideker, T, Kopetz, S, Carey, L, Nath, A, Marcus, D, Regier, AA, Rashid, N, Barzilay, R, Winer, EP, Salgia, R, Malhotra, J, Gentles, A, Buetow, K, Mahmood, F, Markman, DW, Eddy, J, Afkhami, M, Alfaro-Munoz, KD, Alonso Martinez, S, Alpert, K, Anampa, J, Bafna, V, Balic, M, Balko, JM, Barzilay, R, Bates, S, Bekaii-Saab, T, Bernard-Pagan, V, Bild, A, Boland, GM, Borad, MJ, Buetow, K, Buhle, L, Burns, R, Cannon, TL, Carey, LA, Castelnovo, LF, Chen, R, Cianfrocca, M, Clark, A, Hamilton, SR, Kopetz, S, Maru, DM, Menter, DG, Raghav, KS, Rai, K, Tayob, N The ADAPT learning cancer treatment system. Cancer cell 44(3):449-454, 2026. PMID: 41512871.

      Editorials

      1. Sherry AD, Rooney MK, Bernard V, Seo A, Marqueen KE, Schrank BR. Residency Interviews in Radiation Oncology After COVID-19: Perspectives From Recently Matched Applicants. Int J Radiat Oncol Biol Phys 108(2):452-454, 2020. PMID: 32890530.
      2. Bernard V, Herman JM. Pancreas SBRT: Who, What, When, Where, and How.... Pract Radiat Oncol 10(3):183-185, 2020. PMID: 31760165.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 25, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top